Incyte filed a lawsuit to try to block the launch of Leqselvi, claiming that the drug infringed a US patent (No. 9,662,335) ...

Lawyers for AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson argued at a panel hearing in Philadelphia late last week ...

Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated ...

NHS England has started a pilot trial of an iPhone app and device combination that could be used by nursing staff to speed up ...